Company Description
BSF Enterprise PLC (BSF) focuses on unlocking the next generation of biotechnological solutions using cell-based tissue engineering. The company aims to produce cultured meat, lab-grown leather, human corneas, collagen growth, and skin substitutes. With 100% ownership of 3D Bio-Tissues (3DBT), BSF is already producing human corneas and lab-grown meat. The company plans to grow through commercializing 3DBT's IP, pursuing M&A opportunities, and licensing out technologies to manufacturers.
Stock Performance
Latest News
SEC Filings
No SEC filings available for BSF Enterprise PLC.